The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The role of socioeconomic deprivation in gastrointestinal cancer clinical trial enrollment at an NCI-designated comprehensive cancer center.
 
Daniel Strebig
No Relationships to Disclose
 
Taymeyah E. Al-Toubah
No Relationships to Disclose
 
Emily Coughlin
No Relationships to Disclose
 
Rahul Mhaskar
No Relationships to Disclose
 
Sylea Lowery
No Relationships to Disclose
 
Ebin Mathew
No Relationships to Disclose
 
Mitchell Capelli
No Relationships to Disclose
 
Aishwarya Pattnaik
No Relationships to Disclose
 
Kea Turner
No Relationships to Disclose
 
Kedar Kirtane
Stock and Other Ownership Interests - Agenus; Immunomedics; Macrogenics; Myovant Sciences; Oncternal Therapeutics; Seagen; Veru
Consulting or Advisory Role - MyCareGorithm
 
Amina Dhahri
No Relationships to Disclose
 
Richard D. Kim
Consulting or Advisory Role - Bayer; Exelixis; Lilly; Pfizer; QED Therapeutics; Roche/Genentech; SERVIER; Taiho Oncology
Speakers' Bureau - Eisai; Exelixis; Incyte
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst)
 
Jennifer B. Permuth
No Relationships to Disclose
 
Susan Thomas Vadaparampil
Speakers' Bureau - Bristol-Myers Squibb/Medarex (I); GlaxoSmithKline (I)
 
Jason B. Fleming
Stock and Other Ownership Interests - Bio-Path Holdings
Consulting or Advisory Role - Bio-Path Holdings; Candel Therapeutics; Covidien/Medtronic; GlycosBio; MyCareGorithm; PanTher Therapeutics
Patents, Royalties, Other Intellectual Property - U.S. Application No. 15/780,799, based on International Application No. PCT/US2016/065763, entitled “Polymeric Drug Delivery Systems For Treatment of Disease,” by Chun Li et al.; In the Name of Board of Regents, The University of Texas System
 
Jonathan R. Strosberg
Consulting or Advisory Role - Tersera
Speakers' Bureau - Ipsen
Research Funding - ITM Solucin (Inst); Novartis (Inst)
 
Benjamin Daniel Powers
No Relationships to Disclose